Here is What Hedge Funds Think About Symmetry Medical Inc. (SMA)

Page 1 of 2

Symmetry Medical Inc. (NYSE:SMA) investors should be aware of an increase in activity from the world’s largest hedge funds recently.

At the moment, there are dozens of methods investors can use to monitor stocks. A pair of the most useful are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the best fund managers can outpace the market by a superb margin (see just how much).

Symmetry Medical Inc. (NYSE:SMA)

Just as key, positive insider trading activity is a second way to break down the marketplace. There are lots of incentives for an insider to get rid of shares of his or her company, but just one, very simple reason why they would buy. Various empirical studies have demonstrated the valuable potential of this method if investors understand where to look (learn more here).

With all of this in mind, it’s important to take a look at the recent action regarding Symmetry Medical Inc. (NYSE:SMA).

What have hedge funds been doing with Symmetry Medical Inc. (NYSE:SMA)?

Heading into Q2, a total of 14 of the hedge funds we track were bullish in this stock, a change of 56% from one quarter earlier. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few key hedge fund managers who were increasing their stakes substantially.

According to our comprehensive database, Ariel Investments, managed by John W. Rogers, holds the biggest position in Symmetry Medical Inc. (NYSE:SMA). Ariel Investments has a $49.2 million position in the stock, comprising 0.8% of its 13F portfolio. Sitting at the No. 2 spot is SG Capital Management, managed by Ken Grossman and Glen Schneider, which held a $4.9 million position; 2.4% of its 13F portfolio is allocated to the company. Remaining hedgies that are bullish include Joel Greenblatt’s Gotham Asset Management, John Overdeck and David Siegel’s Two Sigma Advisors and Robert B. Gillam’s McKinley Capital Management.

As industrywide interest jumped, some big names have jumped into Symmetry Medical Inc. (NYSE:SMA) headfirst. McKinley Capital Management, managed by Robert B. Gillam, initiated the most outsized position in Symmetry Medical Inc. (NYSE:SMA). McKinley Capital Management had 1.3 million invested in the company at the end of the quarter. Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital also initiated a $0.6 million position during the quarter. The other funds with brand new SMA positions are Ken Griffin’s Citadel Investment Group, Glenn Russell Dubin’s Highbridge Capital Management, and Mike Vranos’s Ellington.

What have insiders been doing with Symmetry Medical Inc. (NYSE:SMA)?

Insider purchases made by high-level executives is most useful when the company in question has seen transactions within the past 180 days. Over the latest half-year time frame, Symmetry Medical Inc. (NYSE:SMA) has seen zero unique insiders buying, and 2 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Symmetry Medical Inc. (NYSE:SMA). These stocks are Cardiovascular Systems Inc (NASDAQ:CSII), Natus Medical Inc (NASDAQ:BABY), GenMark Diagnostics, Inc (NASDAQ:GNMK), Invacare Corporation (NYSE:IVC), and Cynosure, Inc. (NASDAQ:CYNO). This group of stocks belong to the medical appliances & equipment industry and their market caps are similar to SMA’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!